OP 8.4 – 00165 TLR agonist and SIV mAbs administered to SIV-infected ART-suppressed macaques did not delay rebound after treatment interruption

Bibliographic Details
Main Authors: H. King, D. Brammer, C. Lehman, M. Roederer, D. Bolton, R. Mason, K. Song, K. Foulds, J. Lifson, P. Darrah, R. Geleziunas
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Journal of Virus Eradication
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664022002163
_version_ 1797979831342727168
author H. King
D. Brammer
C. Lehman
M. Roederer
D. Bolton
R. Mason
K. Song
K. Foulds
J. Lifson
P. Darrah
R. Geleziunas
author_facet H. King
D. Brammer
C. Lehman
M. Roederer
D. Bolton
R. Mason
K. Song
K. Foulds
J. Lifson
P. Darrah
R. Geleziunas
author_sort H. King
collection DOAJ
first_indexed 2024-04-11T05:44:51Z
format Article
id doaj.art-c49740fab8cb4086b17df5fcee2c92bc
institution Directory Open Access Journal
issn 2055-6640
language English
last_indexed 2024-04-11T05:44:51Z
publishDate 2022-12-01
publisher Elsevier
record_format Article
series Journal of Virus Eradication
spelling doaj.art-c49740fab8cb4086b17df5fcee2c92bc2022-12-22T04:42:15ZengElsevierJournal of Virus Eradication2055-66402022-12-018100278OP 8.4 – 00165 TLR agonist and SIV mAbs administered to SIV-infected ART-suppressed macaques did not delay rebound after treatment interruptionH. King0D. Brammer1C. Lehman2M. Roederer3D. Bolton4R. Mason5K. Song6K. Foulds7J. Lifson8P. Darrah9R. Geleziunas10U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USAVaccine Research Center, NIAID, NIH, Bethesda, MD, USAVaccine Research Center, NIAID, NIH, Bethesda, MD, USAVaccine Research Center, NIAID, NIH, Bethesda, MD, USAU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USAVaccine Research Center, NIAID, NIH, Bethesda, MD, USAVaccine Research Center, NIAID, NIH, Bethesda, MD, USAVaccine Research Center, NIAID, NIH, Bethesda, MD, USAAIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD, USAVaccine Research Center, NIAID, NIH, Bethesda, MD, USAGilead Sciences, Foster City, CA, USAhttp://www.sciencedirect.com/science/article/pii/S2055664022002163
spellingShingle H. King
D. Brammer
C. Lehman
M. Roederer
D. Bolton
R. Mason
K. Song
K. Foulds
J. Lifson
P. Darrah
R. Geleziunas
OP 8.4 – 00165 TLR agonist and SIV mAbs administered to SIV-infected ART-suppressed macaques did not delay rebound after treatment interruption
Journal of Virus Eradication
title OP 8.4 – 00165 TLR agonist and SIV mAbs administered to SIV-infected ART-suppressed macaques did not delay rebound after treatment interruption
title_full OP 8.4 – 00165 TLR agonist and SIV mAbs administered to SIV-infected ART-suppressed macaques did not delay rebound after treatment interruption
title_fullStr OP 8.4 – 00165 TLR agonist and SIV mAbs administered to SIV-infected ART-suppressed macaques did not delay rebound after treatment interruption
title_full_unstemmed OP 8.4 – 00165 TLR agonist and SIV mAbs administered to SIV-infected ART-suppressed macaques did not delay rebound after treatment interruption
title_short OP 8.4 – 00165 TLR agonist and SIV mAbs administered to SIV-infected ART-suppressed macaques did not delay rebound after treatment interruption
title_sort op 8 4 00165 tlr agonist and siv mabs administered to siv infected art suppressed macaques did not delay rebound after treatment interruption
url http://www.sciencedirect.com/science/article/pii/S2055664022002163
work_keys_str_mv AT hking op8400165tlragonistandsivmabsadministeredtosivinfectedartsuppressedmacaquesdidnotdelayreboundaftertreatmentinterruption
AT dbrammer op8400165tlragonistandsivmabsadministeredtosivinfectedartsuppressedmacaquesdidnotdelayreboundaftertreatmentinterruption
AT clehman op8400165tlragonistandsivmabsadministeredtosivinfectedartsuppressedmacaquesdidnotdelayreboundaftertreatmentinterruption
AT mroederer op8400165tlragonistandsivmabsadministeredtosivinfectedartsuppressedmacaquesdidnotdelayreboundaftertreatmentinterruption
AT dbolton op8400165tlragonistandsivmabsadministeredtosivinfectedartsuppressedmacaquesdidnotdelayreboundaftertreatmentinterruption
AT rmason op8400165tlragonistandsivmabsadministeredtosivinfectedartsuppressedmacaquesdidnotdelayreboundaftertreatmentinterruption
AT ksong op8400165tlragonistandsivmabsadministeredtosivinfectedartsuppressedmacaquesdidnotdelayreboundaftertreatmentinterruption
AT kfoulds op8400165tlragonistandsivmabsadministeredtosivinfectedartsuppressedmacaquesdidnotdelayreboundaftertreatmentinterruption
AT jlifson op8400165tlragonistandsivmabsadministeredtosivinfectedartsuppressedmacaquesdidnotdelayreboundaftertreatmentinterruption
AT pdarrah op8400165tlragonistandsivmabsadministeredtosivinfectedartsuppressedmacaquesdidnotdelayreboundaftertreatmentinterruption
AT rgeleziunas op8400165tlragonistandsivmabsadministeredtosivinfectedartsuppressedmacaquesdidnotdelayreboundaftertreatmentinterruption